Stop Deadly Denials Act of 2026

Hozzl · 2026-04-23T09:38:25Z

Explore the details of House Bill 8377 Stop Deadly Denials Act of 2026 currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on undefined. Stay informed on legislative developments.

4/23/2026, 9:38 AM

Summary of Bill HR 8377

This bill, designated as H.R. 8377 in the 119th Congress and introduced on April 20, 2026, aims to amend title XVIII of the Social Security Act to disallow the utilization of prior authorization within Medicare Advantage plans. Additionally, it seeks to modify title XI of the Social Security Act to restrict the rollout of payment models that test prior authorization within traditional Medicare. The bill includes other provisions not specified in the context, providing a comprehensive approach to addressing prior authorization practices in Medicare-related programs.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 8377

Bill HR 8377 is currently in the status of Bill Introduced since April 20, 2026. Bill HR 8377 was introduced during Congress 119 and was introduced to the House on April 20, 2026. Bill HR 8377's most recent activity was Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. as of April 20, 2026

Bipartisan Support of Bill HR 8377

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 8377

Primary Policy Focus

Alternate Title(s) of Bill HR 8377

To amend title XVIII of the Social Security Act to prohibit the use of prior authorization under Medicare Advantage plans, to amend title XI of the Social Security Act to limit the implementation of payment models testing prior authorization under traditional Medicare, and for other purposes.